+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Superior virulence of Mycobacterium bovis over Mycobacterium tuberculosis (Mtb) for Mtb-resistant and Mtb-susceptible mice is manifest as an ability to cause extrapulmonary disease



Superior virulence of Mycobacterium bovis over Mycobacterium tuberculosis (Mtb) for Mtb-resistant and Mtb-susceptible mice is manifest as an ability to cause extrapulmonary disease



Tuberculosis 86(1): 20-27



Mice of a Mycobacterium tuberculosis-resistant (BALB/c) and of a M. tuberculosis-susceptible (DBA/2) strain proved considerably more susceptible, and equally so, to infection with Mycobacterium bovis than with M. tuberculosis when infection was initiated via the iv route. Infection with M. tuberculosis was eventually controlled at an approximately stationary level in the lungs, livers, spleens and kidneys of BALB/c mice, and in all of these organs except the lungs in DBA/2 mice. M. tuberculosis-infected DBA/2 mice died with a much shorter median survival time (MST) than M. tuberculosis-infected BALB/c mice. By contrast, infection with M. bovis killed mice of both strains with the same and much shorter MST. Unexpectedly, M. bovis caused progressive infection and pathology in the livers of BALB/c mice, but not in this organ in DBA/2 mice. More importantly, this pathogen caused progressive infection and infection-induced pathology in the kidneys and adrenal glands of both strains of mice. It is proposed that disease of the adrenal glands might serve to explain why M. bovis caused mice of both strains to die with the same much shorter MST.

(PDF emailed within 0-6 h: $19.90)

Accession: 004478208

Download citation: RISBibTeXText

PMID: 16253563

DOI: 10.1016/j.tube.2005.04.003


Related references

Evolution of cell types and t cell subsets in the spleens of mycobacterium bovis bcg resistant and mycobacterium bovis bcg susceptible strains of mice after infection with mycobacterium bovis bcg. Infection & Immunity 49(1): 253-255, 1985

Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice. Infection and Immunity 63(9): 3428-3437, 1995

Phylogenomic analysis of the species of the Mycobacterium tuberculosis complex demonstrates that Mycobacterium africanum, Mycobacterium bovis, Mycobacterium caprae, Mycobacterium microti and Mycobacterium pinnipedii are later heterotypic synonyms of Mycobacterium tuberculosis. International Journal of Systematic and Evolutionary Microbiology 68(1): 324-332, 2017

Resistance system of Mycobacterium bovis B.C.B. to aminoglycoside- and peptide-antibiotics. Comparison of resistant phenotypes between Mycobacterium tuberculosis and Mycobacterium bovis. Microbiology and Immunology 24(1): 11-19, 1980

Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice. Clinical and Vaccine Immunology 21(10): 1443-1451, 2015

Extrapulmonary dissemination of Mycobacterium bovis but not Mycobacterium tuberculosis in a bronchoscopic rabbit model of cavitary tuberculosis. Infection and Immunity 77(2): 598-603, 2008

In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid. Antimicrobial Agents and ChemoTherapy 31(1): 132-133, 1987

Dna relatedness among selected strains of mycobacterium tuberculosis mycobacterium bovis mycobacterium bovis bcg mycobacterium microti and mycobacterium africanum. International Journal of Systematic Bacteriology 35(2): 147-150, 1985

Infections with mycobacterium avium human mycobacterium bovis mycobacterium tuberculosis mycobacterium kansasii mycobacterium intracellulare mycobacterium xenopei. Lancet (7558): 36, 1968

Monoclonal antibodies for the rapid differentiation of mycobacterium tuberculosis from mycobacterium bovis mycobacterium avium mycobacterium kansasii and mycobacterium xenopi. Abstracts of the Annual Meeting of the American Society for Microbiology 88: 139, 1988

Evolution of cell types and T-cell subsets in the spleens of Mycobacterium bovis BCG-resistant and M. bovis BCG-susceptible strains of mice after infection with M. bovis BCG. Infection and Immunity 49(1): 253-255, 1985

The virulence of resistant strains of Mycobacterium tuberculosis for guinea pigs and experimental therapeutic effects of antitubercular agents on the animals infected by the resistant strains. I. The virulence of the resistant strains of Mycobacterium tuberculosis. Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi 5(4): 204-206, 1982

Catalase-peroxidase of Mycobacterium bovis BCG converts isoniazid to isonicotinamide, but not to isonicotinic acid: differentiation parameter between enzymes of Mycobacterium bovis BCG and Mycobacterium tuberculosis. Biochimica et Biophysica Acta 1760(5): 724-729, 2006

Delayed type skin reactions in guinea pigs sensitized with various acid fast bacilli and tested with protoplasms from homologous and heterologous organisms mycobacterium tuberculosis mycobacterium balnei mycobacterium batteyi mycobacterium bovis mycobacterium kansasii. International Archives Of Allergy & Applied Immunology: 283-292, 1968

Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCG. Journal of Antimicrobial ChemoTherapy 46(4): 565-570, 2000